RG
SUPN icon

Renaissance Group’s Supernus Pharmaceuticals SUPN Stock Holding History

Renaissance Group’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-10,496
Closed -$288K – 285
2019
Q3 		$288K Buy
10,496
+380
+4% +$11.3K 0.01% 236
2019
Q2 		$335K Buy
10,116
+202
+2% +$6.92K 0.01% 239
2019
Q1 		$347K Sell
9,914
-731
-7% -$27.2K 0.01% 236
2018
Q4 		$354K Buy
10,645
+437
+4% +$18.8K 0.02% 229
2018
Q3 		$514K Buy
10,208
+303
+3% +$15K 0.02% 222
2018
Q2 		$593K Sell
9,905
-771
-7% -$39.9K 0.02% 185
2018
Q1 		$489K Buy
10,676
+285
+3% +$11.9K 0.02% 191
2017
Q4 		$414K Buy
10,391
+96
+0.9% +$3.79K 0.01% 217
2017
Q3 		$412K Sell
10,295
-2,936
-22% -$127K 0.01% 207
2017
Q2 		$570K Buy
13,231
+308
+2% +$11K 0.02% 141
2017
Q1 		$404K Sell
12,923
-2,317
-15% -$62.1K 0.02% 165
2016
Q4 		$385K Sell
15,240
-36
-0.2% -$804 0.02% 175
2016
Q3 		$378K Sell
15,276
-1,921
-11% -$43.5K 0.02% 164
2016
Q2 		$350K Sell
17,197
-3,829
-18% -$67.9K 0.01% 173
2016
Q1 		$321K Buy
+21,026
New +$274K 0.01% 173
2015
Q4 		– Sell
-19,873
Closed -$279K – 297
2015
Q3 		$279K Buy
+19,873
New +$370K 0.01% 218

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Renaissance Group's SUPN Position: Q4 2019 in Review

Renaissance Group sold out of Supernus Pharmaceuticals (SUPN) in Q4 2019, closing a stake of 10,496 shares — an estimated $288K sold.

Renaissance Group first reported a position in SUPN in Q3 2015 and held it in 16 quarters. The position peaked at $593K in Q2 2018. 235 funds tracked by Wall St. Rank hold SUPN as of Q4 2019.

  • Renaissance Group reported no remaining Supernus Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Renaissance Group sold 10,496 Supernus Pharmaceuticals shares in Q4 2019, an estimated $288K.
  • Renaissance Group first reported a position in Supernus Pharmaceuticals in Q3 2015 and held it in 16 quarters.
  • Renaissance Group's Supernus Pharmaceuticals position peaked at $593K in Q2 2018.
  • 235 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q4 2019.

Based on Renaissance Group's 13F filing for Q4 2019, filed 12 Feb 2020.